welcome to oneEDSvoice- a positively charged Ehlers Danlos Syndrome community.
- join today!
Fraser C. Henderson, Sr., MD
Neurological Surgeon, Trained Spine Surgeon
The Metropolitan Neurosurgery Group, LLC
Chevy Chase Office
8401 Connecticut Avenue, Suite 220
Chevy Chase, Maryland, United States
Dr. Fraser C. Henderson Sr. is an exceptional neurological surgeon with an extensive experience and vast expertise in all facets of neurosurgery. He serves his patients at the Metropolitan Neurosurgery Group located in Chevy Chase, in the state of Maryland.
Fraser Henderson was foreman on a cattle station in the Outback of Australia before receiving his bachelor’s and Medical degree at the University of Virginia, Charlottesville VA. He served for with the Multi-National Peace Keeping Force in Beirut, earning the Navy Commendation Medal for preparedness of and treatment of mass casualties following the terrorist bombing attack in Beirut, Lebanon, in October 1983. Finishing his tour with the US Navy, Commander Henderson joined Georgetown University, in Washington D.C. as Director of Neurosurgery of the Spine and Cranio-cervical Junction.
Dr. Henderson entered private practice in Bethesda, Maryland, as Director of Neurosurgery at Doctors Hospital and Director of the Chiari Center of Excellence, where he is focused on the development of the understanding and treatment of deformity induced injury to the brainstem and spinal cord in Chiari Malformation and Ehlers Danlos Syndrome.
expertly curated content related to this topic
Benign Hypermobility SyndromeEpidemiology: -Prevalence: 8-20% -Age:...
2018 Alexander technique workshopThe Ehlers-Danlos Society is excited to ...
Homozygosity for a Null Allele of COL3A1 Results in Recessive Ehlers-Danlos SyndromeSo far, mutations in the human COL3A1 ge...
Peter H. Byers, MDPeter H. Byers, MD is a medical Genetici...
Joan Marilyn Stoler, MDDr. Joan Stoler specializes in Pediatric...
Alan Pocinki, MD, PLLCDr. Pocinki is a general internist quali...
Acer Therapeutics and Opexa Therapeutics Sign Merger AgreementOpexa Therapeutics, Inc. (Nasdaq: OPXA) ...